3a-Methyl-2,3,3a,4,5,6-hexahydro-phenalen-1-on | 151005-26-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 3a-Methyl-2,3,3a,4,5,6-hexahydro-phenalen-1-on
• 英文别名: (+/-)-3a-methyl-2,3,3a,4,5,6-hexahydro-1-phenalenone；3a-Methyl-2,3,3a,4,5,6-hexahydro-1-phenalenone；3a-methyl-3,4,5,6-tetrahydro-2H-phenalen-1-one
• CAS: 151005-26-4
• 化学式: C₁₄H₁₆O
• 分子量: 200.28
• InChiKey: JSBWKHBYUNMJDK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3a-Methyl-2,3,3a,4,5,6-hexahydro-phenalen-1-on 在 三氯化铝 sodium tetrahydroborate 、 水 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 以97%的产率得到(+/-)-3a-Methyl-2,3,3a,4-tetrahydro-1H-phenalene
  参考文献：
  名称：

  TRICYCLIC AMINE COMPOUND

  摘要：

  通用公式（I）代表的化合物：[其中R1代表氢原子或C16烷基，A和B代表-(CH2)2-，-(CH2)3-或-(CH2)4-，X代表-N(R2)-（R2代表氢原子或C1-6烷基），-CO-，-C(=N-R3)-（R3代表氢原子或C1-6烷基），或-C(=C(R4)(R5))-（R4和R5独立代表氢原子或C1-6烷基），Ar代表芳基二基团或杂芳基二基团]，具有控制视黄醇生理活性的作用，并可用作药物的活性成分。

  公开号：

  EP2189440A1

文献信息

• TRICYCLIC AMINE COMPOUND
  申请人：Research Foundation Itsuu Laboratory

  公开号：EP2189440A1

  公开（公告）日：2010-05-26

  A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C16 alkyl group, A and B represent -(CH2)2-, -(CH2)3- or -(CH2)4-, X represents -N(R2)- (R2 represents hydrogen atom or a C1-6 alkyl group), -CO-, -C(=N-R3)- (R3 represents hydrogen atom or a C1-6 alkyl group), or - C(=C(R4)(R5))- (R4 and R5 independently represent hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has an action of controlling physiological activities of retinoids and useful as an active ingredient of a medicament.

  通用公式（I）代表的化合物：[其中R1代表氢原子或C16烷基，A和B代表-(CH2)2-，-(CH2)3-或-(CH2)4-，X代表-N(R2)-（R2代表氢原子或C1-6烷基），-CO-，-C(=N-R3)-（R3代表氢原子或C1-6烷基），或-C(=C(R4)(R5))-（R4和R5独立代表氢原子或C1-6烷基），Ar代表芳基二基团或杂芳基二基团]，具有控制视黄醇生理活性的作用，并可用作药物的活性成分。
• Tricyclic amide compound
  申请人：Research Foundation Itsuu Laboratory

  公开号：US08232300B2

  公开（公告）日：2012-07-31

  A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3—or —(CH2)4—, X represents —N(R2)—CO—(R2 represents hydrogen atom or a C1-6 alkyl group), —CO—N(R3)—(R3 represents hydrogen atom or a C1-6 alkyl group), —C(R4)═C(R5)—(R4 and R5 represent hydrogen atom or a C1-6 alkyl group), or —N(R6)—SO2—(R6 represents hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has a retinoid action and is useful as an active ingredient of a medicament.

  以下是一种由下列通式（I）表示的化合物：[其中R1代表氢原子或C1-6烷基，A和B代表—（CH2）2—，—（CH2）3—或—（CH2）4—，X代表—N（R2）—CO—（R2代表氢原子或C1-6烷基），—CO—N（R3）—（R3代表氢原子或C1-6烷基），—C（R4）═C（R5）—（R4和R5代表氢原子或C1-6烷基），或—N（R6）—SO2—（R6代表氢原子或C1-6烷基），Ar代表芳基二烷基或杂芳基二烷基]，具有视黄醇作用，并可作为药物的活性成分使用。
• Tricyclic amine compound
  申请人：Research Foundation Itsuu Laboratory

  公开号：US08143260B2

  公开（公告）日：2012-03-27

  A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3— or —(CH2)4—, X represents —N(R2)— (R2 represents hydrogen atom or a C1-6 alkyl group), —CO—, —C(═N—R3)— (R3 represents hydrogen atom or a C1-6 alkyl group), or —C(═C(R4)(R5))— (R4 and R5 independently represent hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has an action of controlling physiological activities of retinoids and useful as an active ingredient of a medicament.

  以下是一种由以下通式（I）表示的化合物：[其中R1代表氢原子或C1-6烷基，A和B表示—（CH2）2—，—（CH2）3—或—（CH2）4—，X表示—N（R2）—（R2代表氢原子或C1-6烷基），—CO—，—C（═N—R3）—（R3代表氢原子或C1-6烷基），或—C（═C（R4）（R5））—（R4和R5分别代表氢原子或C1-6烷基），以及Ar代表芳基二基团或杂芳基二基团]，该化合物具有调节视黄醇生理活性的作用，是药物的有效成分。
• Protein tyrosine kinase inhibitory properties of planar polycyclics obtained from the marine sponge Xestospongia cf. carbonaria and from total synthesis
  作者：Khisal A. Alvi、Jaime Rodriguez、Maria Cristina Diaz、Robert Moretti、Robert S. Wilhelm、Rita H. Lee、Doris L. Slate、Phillip Crews

  DOI：10.1021/jo00070a023

  日期：1993.8

  Nine related polycyclic quinones and hydroquinones of the halenaquinone class were isolated from two Indo-Pacific collections of the sponge Xestospongia cf. carbonaria. The halenaquinone family appears not to be of polyketide origin but can be biogenetically derived by the union of a sesquiterpene and a quinone. Four new metabolites were characterized including tetrahydrohalenaquinone B (8a), 14-methoxyhalenaquinone (9), xestoquinolide A (10), and xestoquinolide B (11). These were accompanied by five known compounds, halenaquinone (3), halenaquinol (4), halenaquinol sulfate (5), xestoquinone (6), and tetrahydrohalenaquinone A (7a). The new structures were established from 2D NMR data, and the absolute stereochemistry of the chiral centers in 7 and 8 was determined by the formation of 7b and 7c, the bis esters of O-methylmandelic acid. A series of polycyclic models of natural products 3 and 6 were synthesized and included 16-23. The more complex members of this group were assembled via a 4 + 2 cycloaddition between an o-quinodimethane and a functionalized enone. The marine natural products plus two known fungal metabolites, viridin (13) and wortmannin (14), along with halenaquinone synthetic model compounds, were each tested for their ability to inhibit the activity of pp60v-src protein tyrosine kinase (PTK). Halenaquinone and 14-methoxyhalenaquinone were the most potent with IC50 values <10 muM. The other compounds were either less potent or inactive, and a rationalization for this SAR (structure activity relationship) pattern is presented.
• US8143260B2
  申请人：——

  公开号：US8143260B2

  公开（公告）日：2012-03-27